Subtype
Benign Vascular Neoplasm
CI-CAN-00000556Explore in graph →
Non-malignant13 active trials1 evidence items
- NCIt
- C7389
Loading cancer entity…
Subtype
CI-CAN-00000556Explore in graph →
Clinical trials
97 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06798363 | Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma | recruiting | Phase 2 / Phase 3 | 32 | West China HospitalOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07656909 | Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP | recruiting | Phase 2 / Phase 3 | 76 | Yi JiOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT06239480 |
| SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations(SELVA) |
| active not recruiting |
| Phase 3 |
| 51 |
| Palvella Therapeutics, Inc.INDUSTRY |
| 1 |
| Mar 27, 2026 |
| clinicaltrials |
Data updated 5 days agoSource updated Sep 21, 2026source: clinicaltrials